SCHEMBL3549918

SCHEMBL3549918

Cn1cc(/C=C2/C(=O)N3C(C(=O)O)=CS[C@H]23)nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10643498 1.00
SCHEMBL18960787 1.00
SCHEMBL9663942 1.00
SCHEMBL3549923 1.00
SCHEMBL9666157 1.00
Water SCHEMBL10645090 0.99
Water SCHEMBL10642998 0.99
Water SCHEMBL10643003 0.99
Water SCHEMBL10645046 0.99
Water SCHEMBL10644388 0.99

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313980-A1 LACTIVICIN COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS Fedora Pharmaceuticals Inc. (CA) 2024-02-07 EP claimed
WO-2022208356-A1 LACTIVICIN COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS FEDORA PHARMACEUTICALS INC. (CA) 2022-10-06 WO claimed
EP-0291304-B1 PROCESS FOR THE CONVERSION OF THE E-ISOMER OF 6-(SUBSTITUTED METHYLENE)-2-PENEMS INTO THE Z-ISOMER BEECHAM GROUP PLC (GB) 1992-02-26 EP claimed
EP-0154132-B1 6-ALKYLIDENE PENEMS, THEIR PREPARATION AND USE, AND INTERMEDIATES BEECHAM GROUP PLC (GB) 1992-01-08 EP claimed
EP-0291304-A1 Process for the conversion of the E-isomer of 6-(substituted methylene)-2-penems into the Z-isomer BEECHAM GROUP PLC (GB) 1988-11-17 EP claimed
US-4774238-A BACTERICIDES, BETA-LACTAMASE INHIBITORS BEECHAM GROUP PLC (GB) 1988-09-27 US claimed
EP-0210814-A1 6-(Substituted methylene) penems BEECHAM GROUP PLC (GB) 1987-02-04 EP claimed
EP-0154132-A1 6-Alkylidene penems, their preparation and use, and intermediates BEECHAM GROUP PLC (GB) 1985-09-11 EP claimed
US-12274740-B2 Microbiome protection from oral antibiotics THERIVA BIOLOGICS, INC. (US) 2025-04-15 US disclosed
US-20240269247-A1 MICROBIOME PROTECTION FROM ORAL ANTIBIOTICS THERIVA BIOLOGICS, INC. 2024-08-15 US disclosed
US-20240197842-A1 METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS THERIVA BIOLOGICS, INC. 2024-06-20 US disclosed
US-11944669-B2 Method and compositions for inhibiting or preventing adverse effects of oral antibiotics THERIVA BIOLOGICS, INC. (US) 2024-04-02 US disclosed
US-20240082370-A1 SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION THERIVA BIOLOGICS, INC. 2024-03-14 US disclosed
EP-4313980-A1 LACTIVICIN COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS Fedora Pharmaceuticals Inc. (CA) 2024-02-07 EP disclosed
US-4798828-A LACTAMASE INHIBITORS BEECHAM GROUP P.L.C. (GB) 1989-01-17 US disclosed
EP-0291304-A1 Process for the conversion of the E-isomer of 6-(substituted methylene)-2-penems into the Z-isomer BEECHAM GROUP PLC (GB) 1988-11-17 EP disclosed
US-4774238-A BACTERICIDES, BETA-LACTAMASE INHIBITORS BEECHAM GROUP PLC (GB) 1988-09-27 US disclosed
EP-0232966-A1 Process for the preparation of penem compounds and intermediates for this preparation BEECHAM GROUP PLC (GB) 1987-08-19 EP disclosed
EP-0210814-A1 6-(Substituted methylene) penems BEECHAM GROUP PLC (GB) 1987-02-04 EP disclosed
EP-0154132-A1 6-Alkylidene penems, their preparation and use, and intermediates BEECHAM GROUP PLC (GB) 1985-09-11 EP disclosed